|
3006
|
GKT137831
|
First-in-class dual NADPH oxidase (Nox) 1/4 inhibitor |
€80.00 |
|
2064
|
Glibenclamide potassium salt
|
KATP channel blocker; inhibits SUR1 |
€50.00 |
|
4299
|
Gliocidin
|
IMPDH2 inhibitor; Nicotinamide-mimetic prodrug |
€90.00 |
|
3503
|
Glipizide
|
KATP channel blocker; inhibits SUR1 |
€50.00 |
|
3707
|
GLN-1062
|
Brain-pentrant prodrug of galantamine; Acetylcholinesterase inhibitor |
€120.00 |
|
1132
|
GLP-1 antagonist
|
GLP-1 Receptor Antagonist |
€150.00 |
|
1907
|
GLP-1R agonist DMB
|
GLP-1 Receptor (GLP1R) Agonist |
€99.00 |
|
4006
|
GLPG-0634
|
The first orally-available, selective inhibitor of JAK1 |
Inquire |
|
3094
|
GLPG1690
|
First-in-class, potent ATX inhibitor |
€110.00 |
|
3917
|
GLPG2534
|
Potent, selective and orally active IRAK4 inhibitor |
€150.00 |
|
1120
|
Glutapyrone
|
Atypical neuromodulator |
€145.00 |
|
2572
|
GlyH 101
|
Highly potent and selective CFTR inhibitor |
€105.00 |
|
1289
|
GMC 1-109
|
Clozapine analog devoid of DA, 5-HT2, H1 and α1 affinities, but with high M1 affinity |
€125.00 |
|
1151
|
GMC 1-116
|
Clozapine analogue |
€140.00 |
|
2851
|
GMC 1-161
|
Clozapine analog with 5-HT2A, M1 and D2 affinity, devoid of D1 affinities |
€135.00 |
|
1152
|
GMC 1-165
|
Clozapine analog with 5-HT2A and M1 affinity, devoid of D1/D2 affinities |
€140.00 |
|
1148
|
GMC 1-169
|
Atypical antipsychotic |
€150.00 |
|
1082
|
GMC 15-27
|
5-HT1B and 5-HT1D antagonist |
€140.00 |
|
1083
|
GMC 2-113
|
5-HT1B antagonist |
€155.00 |
|
1084
|
GMC 2-118
|
5-HT1B antagonist |
Inquire |
|
1080
|
GMC 2-29
|
5-HT1B and 5-HT1D antagonist |
€145.00 |
|
1150
|
GMC 2-83
|
Atypical antipsychotic |
€160.00 |
|
1081
|
GMC 3-15
|
5-HT1B and 5-HT1D antagonist |
€145.00 |
|
1149
|
GMC 61-39
|
Atypical antipsychotic |
Inquire |
|
2994
|
GNE 317
|
Brain-penetrant PI3K inhibitor (p110-α specific) |
€85.00 |
|
2348
|
GNE 7915
|
Potent, selective, metabolically stable, and brain-penetrable LRRK2 inhibitor |
€110.00 |
|
3625
|
GNE-3511
|
Potent, selective, orally bioavailable and brain-penetrant DLK inhibitor |
€90.00 |
|
4127
|
GNE-781
|
Highly potent, selective, and orally bioavailable CBP inhibitor |
€160.00 |
|
1882
|
GNF 2
|
Inhibitor of Bcr-Abl tyrosine kinase |
€110.00 |
|
2248
|
GNF 5837
|
Potent, selective, and orally bioavailable tropomyosin receptor kinase (Trk) inhibitor |
€90.00 |